NCT00796601View on ClinicalTrials.gov

Maintenance of Efficacy.

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 1, 2009

Primary Completion Date

May 1, 2010

Study Completion Date

November 1, 2010

Conditions
Fibromyalgia
Interventions
DRUG

Esreboxetine

Film coated tablets (2, 6, 8, 10 mg esreboxetine), once daily for 6 months

DRUG

Placebo

Film coated tablets (0 mg esreboxetine), once daily for 6 months

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY